← Open Payments lookup

KIRSTEN WERNER: Open Payments

NPI 1518322767 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,100 in 181 payments from 22 companies in 2025. Trend: 2023 $1,881 · 2024 $2,734 · 2025 $3,100

Food & beverage: $3,100
CompanyPaymentsAmount
Novo Nordisk Inc32$573
ABBVIE INC.36$488
Otsuka America Pharmaceutical, Inc.17$238
PFIZER INC.10$185
GlaxoSmithKline, LLC.11$179
Neurocrine BioSciences, Inc.7$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$146
Boehringer Ingelheim Pharmaceuticals, Inc.8$143
AstraZeneca Pharmaceuticals LP7$143
Lundbeck LLC5$137

Products named: REXULTI, Wegovy, VRAYLAR, TRELEGY ELLIPTA, UBRELVY, Ozempic, INGREZZA, CAPLYTA.

Industry payments across MI — which companies pay providers there.